Brighton Jones’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
Brighton Jones's TXG Position: Q3 2026 in Review
Brighton Jones reduced its 10x Genomics (TXG) stake by 7.5% in Q3 2026, selling an estimated $98.7K and leaving 20,666 shares worth $1.87M. The position accounts for 0.03% of the portfolio, ranked #332.
Brighton Jones first reported a position in TXG in Q1 2021 and has held it in 10 quarters since. 377 funds tracked by Wall St. Rank hold TXG as of Q3 2026.
- Brighton Jones held 20,666 shares of 10x Genomics worth $1.87M as of Q3 2026.
- Brighton Jones sold 1,687 10x Genomics shares in Q3 2026, an estimated $98.7K.
- 10x Genomics made up 0.03% of Brighton Jones's portfolio in Q3 2026, its #332 holding.
- Brighton Jones first reported a position in 10x Genomics in Q1 2021 and has held it in 10 quarters since.
- 377 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.